EDP · Tablet
EDP 7OH Chewable Tablets
Kratom-alkaloid tablet. Every claim below links to a primary source.
- Brand
- EDP
- Product type
- Kratom-alkaloid tablet
- Label claim
- 40 mg per pack, 20 mg per tablet (label)
- Compounds named
- 7-OH (7-hydroxymitragynine); MGPI (mitragynine pseudoindoxyl); Mitragynine
Label versus lab: Lab found MGPI (MGPI has been in temporary Schedule I since August 26, 2026) that the label does not list.
Lab findings
7-OH (7-hydroxymitragynine): Measured close to the labeled amount.
Forensic lab alert: CFSRE forensic testing, May 2026 (opens in a new tab)
MGPI (mitragynine pseudoindoxyl): Found; not on the label.
Forensic lab alert: CFSRE forensic testing, May 2026 (opens in a new tab)
Mitragynine: Small amount found.
Forensic lab alert: CFSRE forensic testing, May 2026 (opens in a new tab)
FDA actions naming the firm
FDA's announcement dated July 15, 2025 says it sent a warning letter to Relax Relief Rejuvenate Trading, LLC dba RRR Trading or EDP Kratom for illegally marketing products containing 7-OH. The letter concerns the firm; it is not a finding about every product it sells.
· FDA warning letter: FDA press announcement, July 15, 2025 (opens in a new tab)
See something wrong? Report an error or ask for a correction. We do not publish individual store names. Methodology: how we decide what to publish.